Software as a Medical Device (SaMD)

Software as a Medical Device (SaMD) - Axcellant

Software as a Medical Device (SaMD)

  1. lut 28, 2025

What Does the 'Software as a Medical Device (SaMD)’ Mean?

Software as a Medical Device (SaMD) refers to software intended to be used for one or more medical purposes that perform these purposes without being part of a hardware medical device. This category includes software applications that can be run on general-purpose computing platforms or mobile devices, and are designed to assist in the diagnosis, treatment, or prevention of diseases or other conditions.

SaMD is distinct from software that is integral to the functioning of a medical device (embedded software). It is regulated as a medical device in its own right, subject to regulatory oversight by bodies such as the FDA in the United States or the European Medicines Agency in the EU, to ensure its safety and effectiveness in healthcare applications.

Why Is the 'Software as a Medical Device (SaMD)’ Important in Clinical Research?

SaMD is crucial in clinical research as it enables the development and use of innovative digital tools for data collection, analysis, and patient monitoring. These software solutions can streamline research processes, improve data accuracy, and facilitate remote patient engagement, potentially leading to more efficient and cost-effective clinical trials.

Understanding SaMD is essential for researchers and sponsors to navigate regulatory requirements and ensure compliance throughout the clinical research lifecycle. Proper classification and validation of SaMD can impact study design, data integrity, and the overall success of clinical trials, making it a critical consideration in modern research methodologies.

Good Practices and Procedures

  1. Implement a robust risk management process, including continuous risk assessment and mitigation strategies throughout the SaMD lifecycle.
  2. Establish a comprehensive cybersecurity framework to protect patient data and ensure the integrity of the software’s functionality.
  3. Develop and maintain a rigorous version control system to track changes, facilitate audits, and manage software updates in compliance with regulatory requirements.
  4. Conduct thorough usability testing with intended end-users to optimize the user interface and minimize the potential for use errors in clinical settings.
  5. Implement a post-market surveillance program to monitor real-world performance, collect user feedback, and promptly address any emerging safety or efficacy concerns.

Related Terms

Read more

How clinical trials can become a strategic asset for biotech startups

Clinical trials are often seen as a regulatory necessity, but for biotech and medtech startups, they can be much more.…

Advancing PET Innovation at SNMMI 2025

Axcellant participated in SNMMI’s 2025 Annual Meeting in New Orleans, where nearly 8,000 professionals in nuclear medicine and molecular imaging gathered…

Insights from Turku PET Symposium 2025

Axcellant participated in the PET Symposium 2025, held in Turku, marking 50 years of PET radiochemistry at the Turku PET…